Bharat Book Bureau

Archives for Therapy

The Arrhythmia Partnering 2007-2012 report provides understanding and access to the arrhythmia partnering deals and agreements entered into by the worlds leading healthcare companies. * Trends in arrhythmia partnering deals * Top arrhythmia deals by value * Deals listed by company A-Z, industry sector, stage of development, technology type http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/arrhythmia-partnering-2007-2012.html Description Arrhythmia Partnering 2007-2012 provides… » read more

Posted by bharatbook

“Drug Discovery and Preclinical Molecules by Therapy Area – Innovation Focuses on Stem Cell Therapies and Gene Therapies”, provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immunologic Disorders, Infection, Cardiovascular Disease and Oncology therapeutic markets. The report analyzes the early stage… » read more

Posted by bharatbook

What does the future hold for small-molecule cancer treatments? Visiongain’s report shows you potential revenues to 2021, discussing trends and opportunities in that market. Find revenue predictions at overall world market, product and national levels to 2021. Through our research and analysis we aim to save you time and help in your decisions. Where are… » read more

Posted by bharatbook

What are the prospects for emerging antibody technologies? Visiongain’s report shows you potential revenues to 2021, discussing R&D trends and opportunities. A new generation of therapeutic antibody is coming. Discover revenue predictions for emerging antibody technologies at total world and submarket levels to 2021. Through our research and analysis we aim to save you time… » read more

Posted by bharatbook

Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in… » read more

Posted by bharatbook

Chronic lymphocytic leukemia is the second most common cancer in adult males and rarely occurs in children. The risk of chronic lymphocytic leukemia is closely associated with age. About 90% of chronic lymphocytic leukemia is diagnosed in middle age. Incidence rate of CLL is high in men and women over 50 years of age. The… » read more

Posted by bharatbook

HIV endemic has had devastating economic, social, health and psychological impacts over the years affecting millions of households in a significant manner over the last decade. Despite the concrete efforts from authorities and various philanthropic institutions, the numbers are still on an upward trend with a total of 33.3 Million HIV victims across the world… » read more

Posted by bharatbook

The Lung Cancer Disease and Therapy Review provides an overview of small cell and non-small cell lung cancer, with incidence, prevalence, and mortality numbers for major countries worldwide, information on diagnosis, and an overview of treatment. General information on the lung cancer market, as well as sales of leading drugs and therapies are provided. http://www.bharatbook.com/detail.asp?id=219236&rt=Disease-and-Therapy-Review-Lung-Cancer.html… » read more

Posted by bharatbook

Vascular Endothelial Growth Factor (VEGF), which plays an important role in angiogenesis, has been extensively studied and over-expression is seen in many cancers. Today, VEGF is targeted using antibodies and tyrosine kinase inhibitors, and antiangiogenic therapy is a standard treatment for many cancers, including colorectal and non-small cell lung cancer. http://www.bharatbook.com/detail.asp?id=213739&rt=VEGF-Inhibition-Therapy-Indicating-and-Prognostic-Biomarkers-2011.html While VEGF inhibitors such… » read more

Posted by bharatbook

This report provides a comprehensive review of 27 candidate therapeutic antibodies and 42 candidate vaccines that are being evaluated for the treatment of lung cancer, covering pipeline, disease-targeting strategies and clinical findings. These antibodies are directed at 17 targets, while the vaccines are directed at 24 antigens or antigen combinations. http://www.bharatbook.com/detail.asp?id=213740&rt=Lung-Cancer-Vaccines-and-Therapeutic-Antibodies-Pipeline-Strategies-and-Clinical-2011.html Globally, lung cancer is… » read more

Posted by bharatbook